Adenocarcinoma

Oncology·MeSH: Adenocarcinoma

Prevalence

5.0 / 100K

208 drugs in development·59 companies·8 clinical trials

Drug Pipeline by Phase

Approved(11)

Drug	Company
calcium gluconate in	Amneal Pharmaceuticals, Inc. (AMRX)
cyclophosphamide	NEXUS BIOPHARMA INC (NEXS)
Cyramza	ELI LILLY & Co (LLY)
Cyramza®	ELI LILLY & Co (LLY)
esoguard	Lucid Diagnostics Inc. (LUCD)
keytruda qlex	Merck & Co., Inc. (MRK)
ogivri	Mylan II B.V. (MYL)
onivyde	MERRIMACK PHARMACEUTICALS INC (MACK)
Ontruzant (SB3)	Organon & Co. (OGN)
tevimbra	BeOne Medicines Ltd. (ONC)
Zenocutuzumab (Zeno) / BIZENGRI® (zenocutuzumab-zbco)	Merus N.V. (MRUS)

Phase 3(58)

Drug	Company
[18F]FAPI-74 PET/CT	ENANTA PHARMACEUTICALS INC (ENTA)
5-FU	Tango Therapeutics, Inc. (TNGX)
ARM C FOLFIRI	IGM Biosciences, Inc. (IGMS)
AZD0901	ASTRAZENECA PLC (AZN)
Base-edited hematopoietic stem and progenitor cells	Merus N.V. (MRUS)
batiraxcept	Aravive, Inc. (ARAV)
Bicalutamide	ARS Pharmaceuticals, Inc. (SPRY)
brachytherapy	GH Research PLC (GHRS)
Cadonilimab	Merus N.V. (MRUS)
Camrelizumab and Chemotherapy	Amneal Pharmaceuticals, Inc. (AMRX)
CAN-2409	Candel Therapeutics, Inc. (CADL)
Chemotherapy	IGM Biosciences, Inc. (IGMS)
Chemotherapy	Amneal Pharmaceuticals, Inc. (AMRX)
degarelix	KYNTRA BIO INC. (KYNB)
Domvanalimab	Arcus Biosciences, Inc. (RCUS)
Erlotinib Hydrochloride	Amneal Pharmaceuticals, Inc. (AMRX)
flot chemotherapy	ASTRAZENECA PLC (AZN)
Flutamide	ARS Pharmaceuticals, Inc. (SPRY)
FOLFIRI+cetuximab	IGM Biosciences, Inc. (IGMS)
Folfirinox	Tango Therapeutics, Inc. (TNGX)
FOLFIRINOX neoadjuvant chemotherapy	Merus N.V. (MRUS)
FOLFOX	Merus N.V. (MRUS)
FOLFOX neoadjuvant chemotherapy	Merus N.V. (MRUS)
FOLFOX-4	IGM Biosciences, Inc. (IGMS)
FOLFOX-7	IGM Biosciences, Inc. (IGMS)
folinic acid	Merus N.V. (MRUS)
Goserelin acetate	KYNTRA BIO INC. (KYNB)
histrelin acetate	KYNTRA BIO INC. (KYNB)
Hyperthermic Intraperitoneal Chemotherapy	Merus N.V. (MRUS)
intravenous tislelizumab	BeOne Medicines Ltd. (ONC)
Intravenous Tislelizumab	BeOne Medicines Ltd. (ONC)
l-leucovorin	Merus N.V. (MRUS)
leucovorin	BeOne Medicines Ltd. (ONC)
Leucovorin	Amneal Pharmaceuticals, Inc. (AMRX)
Leucovorin	Arcus Biosciences, Inc. (RCUS)
Leucovorin	BeOne Medicines Ltd. (ONC)
Leucovorin Calcium	Amneal Pharmaceuticals, Inc. (AMRX)
Leucovorin Calcium	Arcus Biosciences, Inc. (RCUS)
Leucovorin/levofolinate calcium	Merck & Co., Inc. (MRK)
Leucovorin/levofolinate calcium	Merus N.V. (MRUS)
Leuprolide acetate	KYNTRA BIO INC. (KYNB)
mFOLFIRINOX infusion	Tango Therapeutics, Inc. (TNGX)
Nilutamide	ARS Pharmaceuticals, Inc. (SPRY)
nis793	Novartis AG (NVS)
Olaparib	Merck & Co., Inc. (MRK)
panitumumab	GH Research PLC (GHRS)
Pemetrexed	ELI LILLY & Co (LLY)
Quemliclustat	Arcus Biosciences, Inc. (RCUS)
ramucirumab	GH Research PLC (GHRS)
Regorafenib	UNITED THERAPEUTICS Corp (UTHR)
relacorilant	CORCEPT THERAPEUTICS INC (CORT)
Standard adjuvant chemotherapy	Merus N.V. (MRUS)
subcutaneous tislelizumab	BeOne Medicines Ltd. (ONC)
Subcutaneous Tislelizumab	BeOne Medicines Ltd. (ONC)
tislelizumab	BeOne Medicines Ltd. (ONC)
zanidatamab	GH Research PLC (GHRS)
Zimberelimab	Arcus Biosciences, Inc. (RCUS)
zolbetuximab	Merus N.V. (MRUS)

Phase 2(55)

Drug	Company
ACR-368	Acrivon Therapeutics, Inc. (ACRV)
Antiandrogen Therapy	Royalty Pharma plc (RPRX)
Arm A - Olaparib	IGM Biosciences, Inc. (IGMS)
Autogene cevumeran	Merus N.V. (MRUS)
Autogene cevumeran	Tango Therapeutics, Inc. (TNGX)
Budigalimab	AbbVie Inc. (ABBV)
BXCL701	BioXcel Therapeutics, Inc. (BTAI)
BXCL701	Merck & Co., Inc. (MRK)
Cabozantinib	ENANTA PHARMACEUTICALS INC (ENTA)
cetuximab	Verastem, Inc. (VSTM)
Chemotherapeutic Agent	Merus N.V. (MRUS)
Clobetasol Propionate	UNITED THERAPEUTICS Corp (UTHR)
Degarelix	ARS Pharmaceuticals, Inc. (SPRY)
Dostarlimab	IGM Biosciences, Inc. (IGMS)
etrumadenant	Arcus Biosciences, Inc. (RCUS)
Filgrastim	Replimune Group, Inc. (REPL)
FLOT	Arcus Biosciences, Inc. (RCUS)
FOLFOX regimen	IGM Biosciences, Inc. (IGMS)
Gemzar	Zentalis Pharmaceuticals, Inc. (ZNTL)
Goserelin Acetate	ARS Pharmaceuticals, Inc. (SPRY)
HRS-4642+AG+Nimotuzumab	Merus N.V. (MRUS)
IM96 CAR-T Cells	Merus N.V. (MRUS)
increase dose of tocilizumab	Merus N.V. (MRUS)
Leucovorin	AbbVie Inc. (ABBV)
Leucovorin	UNITED THERAPEUTICS Corp (UTHR)
Leucovorin	Jazz Pharmaceuticals plc (JAZZ)
Leuprolide Acetate	ENANTA PHARMACEUTICALS INC (ENTA)
Leuprolide Acetate	ARS Pharmaceuticals, Inc. (SPRY)
Levoleucovorin Calcium	UNITED THERAPEUTICS Corp (UTHR)
lp-300	Lantern Pharma Inc. (LTRN)
lsta1	LISATA THERAPEUTICS, INC. (LSTA)
Methoxyamine	Merus N.V. (MRUS)
Methoxyamine	ADMA BIOLOGICS, INC. (ADMA)
Methoxyamine	ENANTA PHARMACEUTICALS INC (ENTA)
mFOLFOX	Jazz Pharmaceuticals plc (JAZZ)
Niraparib	IGM Biosciences, Inc. (IGMS)
nuzefatide pevedotin	BICYCLE THERAPEUTICS PLC (BCYC)
OSE2101	IGM Biosciences, Inc. (IGMS)
Pegfilgrastim	Replimune Group, Inc. (REPL)
PF-08634404	Merus N.V. (MRUS)
Propranolol Hydrochloride	UNITED THERAPEUTICS Corp (UTHR)
QL1706	ENANTA PHARMACEUTICALS INC (ENTA)
ramucirumab	Sanofi (SNY)
Ramucirumab	Jazz Pharmaceuticals plc (JAZZ)
Relugolix	KYNTRA BIO INC. (KYNB)
Talazoparib	KYNTRA BIO INC. (KYNB)
Tocilizumab	Arcus Biosciences, Inc. (RCUS)
triptorelin	KYNTRA BIO INC. (KYNB)
Tucatinib	Merus N.V. (MRUS)
tusamitamab ravtansine	Sanofi (SNY)
utidelone	BIOSTAR PHARMACEUTICALS, INC. (BSPM)
vcn-01	Theriva Biologics, Inc. (TOVX)
Veliparib	IGM Biosciences, Inc. (IGMS)
vs-7375	Verastem, Inc. (VSTM)
Zentalis	Zentalis Pharmaceuticals, Inc. (ZNTL)

Phase 1(50)

Drug	Company
[177lu]lu-nns309	Novartis AG (NVS)
[68ga]ga-nns309	Novartis AG (NVS)
[ga-68]-pnt6555	ELI LILLY & Co (LLY)
[lu-177]-pnt6555	ELI LILLY & Co (LLY)
177lu-dfc413	Novartis AG (NVS)
5-FU	Xencor Inc (XNCR)
68ga-dfc413	Novartis AG (NVS)
68ga-nns309	Novartis AG (NVS)
Androgen Deprivation Therapy	Janux Therapeutics, Inc. (JANX)
Anetumab Ravtansine	ENANTA PHARMACEUTICALS INC (ENTA)
anti-pd-1	TriSalus Life Sciences Inc. (TLSI)
ASP2138	ENANTA PHARMACEUTICALS INC (ENTA)
ASP2138	Tango Therapeutics, Inc. (TNGX)
ASP2138	Xencor Inc (XNCR)
ASP2138	Merus N.V. (MRUS)
ATG-022	Merck & Co., Inc. (MRK)
ba3182	BioAtla, Inc. (BCAB)
BA3182 (CAB-EpCAM x CAB-CD3)	BioAtla, Inc. (BCAB)
BET Bromodomain Inhibitor ZEN-3694	FATE THERAPEUTICS INC (FATE)
Birinapant	IGM Biosciences, Inc. (IGMS)
Botensilimab	AGENUS INC (AGEN)
CAPOX	Merck & Co., Inc. (MRK)
Cemiplimab	Crinetics Pharmaceuticals, Inc. (CRNX)
Emavusertib	Amneal Pharmaceuticals, Inc. (AMRX)
Encorafenib	FATE THERAPEUTICS INC (FATE)
FOLFIRI	IGM Biosciences, Inc. (IGMS)
IDE397	IDEAYA Biosciences, Inc. (IDYA)
IDE892	IDEAYA Biosciences, Inc. (IDYA)
JSB462 Dose 1 QD	Merus N.V. (MRUS)
JSB462 Dose 2 QD	Merus N.V. (MRUS)
leucovorin	ELI LILLY & Co (LLY)
Leucovorin	Xencor Inc (XNCR)
ly3962673	ELI LILLY & Co (LLY)
ly4066434	ELI LILLY & Co (LLY)
mFOLFIRINOX	BioNTech SE (BNTX)
mFOLFIRINOX	Aclaris Therapeutics, Inc. (ACRS)
mvt-1075	MABVAX THERAPEUTICS HOLDINGS, INC. (MBVX)
mvt-2163	MABVAX THERAPEUTICS HOLDINGS, INC. (MBVX)
ONT01	ENANTA PHARMACEUTICALS INC (ENTA)
Pemetrexed	ADMA BIOLOGICS, INC. (ADMA)
Peposertib	Accustem Sciences Inc. (ACUT)
Pidnarulex	Crinetics Pharmaceuticals, Inc. (CRNX)
PTM-101	Merus N.V. (MRUS)
Ramucirumab	Xencor Inc (XNCR)
Ramucirumab	Tango Therapeutics, Inc. (TNGX)
RP2	Replimune Group, Inc. (REPL)
tagmokitug	Coherus Oncology, Inc. (CHRS)
Zunsemetinib	Merus N.V. (MRUS)
Zunsemetinib	KYNTRA BIO INC. (KYNB)
Zunsemetinib	Tango Therapeutics, Inc. (TNGX)

Preclinical(3)

Drug	Company
be-smart	ProPhase Labs, Inc. (PRPH)
neo-stc-01	Neon Therapeutics, Inc. (NTGN)
VPS4A inhibitors (novel series)	Calithera Biosciences, Inc. (CALA)

Phase 1/Phase 2(9)

Drug	Company
[203pb]pb-psv359	Perspective Therapeutics, Inc. (CATX)
[212pb]pb-psv359	Perspective Therapeutics, Inc. (CATX)
avelumab	VACCINEX, INC. (VCNX)
Cetuximab	ELI LILLY & Co (LLY)
Chemotherapy	Merus N.V. (MRUS)
eli-002 7p	Elicio Therapeutics, Inc. (ELTX)
PSV359	Perspective Therapeutics, Inc. (CATX)
Pumitamig	BioNTech SE (BNTX)
sd-101	TriSalus Life Sciences Inc. (TLSI)

Phase 2/Phase 3(7)

Drug	Company
CAPOX	BRISTOL MYERS SQUIBB CO (BMY)
fluoropyrimidine-	BIOSTAR PHARMACEUTICALS, INC. (BSPM)
FOLFOX	BRISTOL MYERS SQUIBB CO (BMY)
folinic acid/ leucovorina	AbbVie Inc. (ABBV)
navlimetostat	BRISTOL MYERS SQUIBB CO (BMY)
pd-1 inhibitor	BIOSTAR PHARMACEUTICALS, INC. (BSPM)
Telisotuzumab Adizutecan	AbbVie Inc. (ABBV)

Phase 4(15)

Drug	Company
adjuvant chemotherapy	Merus N.V. (MRUS)
Androgen Deprivation Therapy	Royalty Pharma plc (RPRX)
Androgen-deprivation Therapy	Royalty Pharma plc (RPRX)
Baxdrostat and dapagliflozin	Travere Therapeutics, Inc. (TVTX)
Brachytherapy	KYNTRA BIO INC. (KYNB)
Cetuximab	IGM Biosciences, Inc. (IGMS)
Dapagliflozin along with standard medical therapy	Travere Therapeutics, Inc. (TVTX)
Dapagliflozin Propanediol	Travere Therapeutics, Inc. (TVTX)
Darolutamide 300 mg tablets	KYNTRA BIO INC. (KYNB)
Leucovorin Calcium	IGM Biosciences, Inc. (IGMS)
Ramucirumab	ENANTA PHARMACEUTICALS INC (ENTA)
SOX chemotherapy	Merus N.V. (MRUS)
Talazoparib with enzalutamide	KYNTRA BIO INC. (KYNB)
tislelizumab	GH Research PLC (GHRS)
Zibotentan/Dapagliflozin FDC	Travere Therapeutics, Inc. (TVTX)

Compare drugs

calcium gluconate in vs cyclophosphamide calcium gluconate in vs Cyramza calcium gluconate in vs esoguard

Frequently asked questions

How many drugs are in development for Adenocarcinoma?

BioSniper tracks 208 drugs in development for Adenocarcinoma across 59 companies.

How many clinical trials target Adenocarcinoma?

There are 8 clinical trials targeting Adenocarcinoma tracked by BioSniper.

What is the prevalence of Adenocarcinoma?

The estimated prevalence of Adenocarcinoma is approximately 5.0 per 100,000 population.

Deep-dive into Adenocarcinoma

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis